Definitive Contract 36C25625C0001
Award Date
10/1/24
Potential Completion Date
9/30/29
Potential Value
$1M
Funding Federal Agency
Veterans Integrated Service Network 17
Contracting Federal Agency
Veterans Integrated Service Network 16
Awardee
Fulgent Therapeutics LLC
Ultimate Awardee
Fulgent Genetics, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
El Monte, CA 91731, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,849,000.00 Firm Fixed Price Delivery Order contract awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The contract provides for GERMLINE PGX MOLECULAR TESTING services with a period of performance through September 29, 2029. This award is part of a larger $99,032,828.20 multiple-award Indefinite Delivery/Indefinite Quantity (IDIQ) contract held by Fulgent Genetics with...
This federal contract award was issued by the Department of Veterans Affairs Veterans Health Administration to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a provider of genomic testing services and COVID-19 testing kits and services to U.S. federal government agencies. The contract is for germline genetic testing with a potential value of $150,000.00 and is a Firm Fixed Price BPA Call order. Fulgent Therapeutics holds a separate $950,000.00 Blanket Purchase Agreement from...
This is a $6,573,600 Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded by the U.S. Department of Veterans Affairs (VA) Strategic Acquisition Center-Frederick to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc. The contract is for germline genetic testing services in support of the VA's National Oncology Program (NOP) and has a period of performance through September 29, 2029. This contract is not designated as a set-aside. Fulgent Therapeutics is an experienced...
This is a $6,489,759.80 firm fixed price Indefinite Delivery/Indefinite Quantity (IDIQ) contract awarded by the Department of Veterans Affairs (VA) Strategic Acquisition Center to Fulgent Therapeutics LLC, a subsidiary of Fulgent Genetics, Inc., for germline genetic testing services. The contract has a 3-year term through September 2025 and is not set-aside. The contract will provide national access to specialized comprehensive reference laboratory testing services, including mandatory...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price purchase order to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for $201,500 to provide clinical genetic testing services for chronic kidney disease. The contract has a performance period through January 17, 2024. Fulgent Diagnostics is a division of Fulgent Genetics, Inc., which specializes in genetic and genomic testing services for the federal government, including the VA,...
This is a firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 20 (VISN 20) of the U.S. Department of Veterans Affairs (VA) to Fulgent Genetics, Inc., a for-profit genetic testing and diagnostics company. The contract, valued at $296,400.00, is for genetic testing services to be provided to the VA Portland Health Care System. The award does not utilize a set-aside designation, indicating Fulgent Genetics competed in an open federal procurement process. This contract...
The Department of Veterans Affairs Veterans Health Administration awarded Fulgent Therapeutics LLC a $3.2 million firm fixed price delivery order against its Medical Laboratory Testing and Analysis Services GSA Schedule contract. Fulgent Therapeutics, doing business as Fulgent Diagnostics and a division of Fulgent Genetics, will provide COVID-19 cost per test services to VHA's Veterans Integrated Service Network 21 through December 2020. The contract supports VHA's coronavirus disease testing...
This federal contract award to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, is a $935,715 firm fixed price purchase order for NEXT GEN TESTING AT MAMC, awarded by the U.S. Army Medical Command. The contract has a period of performance through September 30, 2019 and does not have a set-aside designation. Fulgent Therapeutics is a subsidiary of Fulgent Genetics, Inc., a provider of comprehensive genomic testing services to various federal agencies including the Department of...
This is a definitive contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, for SARS-COV-2 genomic sequencing services. The firm fixed price contract has a potential value of $40,517,395.00 and a completion date of March 10, 2022. Fulgent Diagnostics is a division of Fulgent Genetics, Inc. and has provided genetic and genomic testing services to various federal agencies,...
This is a firm fixed price purchase order awarded by the Department of Veterans Affairs (VA) to Fulgent Therapeutics LLC, doing business as Fulgent Diagnostics, a subsidiary of Fulgent Genetics, Inc. The contract is for the delivery of laboratory testing kits, with a ceiling value of $889,097.43 and a period of performance through December 30, 2024. There was no set-aside designation used for this award. Fulgent Diagnostics is a provider of genomic testing services and COVID-19 testing kits...